ADA26: AstraZeneca unveils positive data for Phase III-ready oral GLP-1RA
AstraZeneca has unveiled data from two Phase IIb trials of its in-licensed oral glucagon-like peptide-1 receptor agonist (GLP-1RA), touting a…
Metabolic Disorders
-
-
ADA26: Kidney disease analysis given spotlight
At this year’s American Diabetes Association (ADA) congress, while obesity and diabetes treatments took the limelight, there were sessions focused…
-
ADA26: T1 and T2 diabetes readouts from Roche, MannKind and Lilly
The past weekend has seen a number of major data presentations at the American Diabetes Association (ADA) conference 2026. While…
-
Rezolute’s stock up on interim Phase III tumour HI data
Rezolute’s second Phase III trial of ersodetug, this time in tumour hyperinsulinism (HI), is yielding more promising data, prompting the company’s…
-
Lilly’s weight loss pill shows 13% weight loss in adults over 65 years of age
Eli Lilly’s Foundayo (orforglipron) has led to weight loss of 13% in post-hoc analysis of patients aged over 65 from…
-
ECO 2026: targeting organs, not just weight, defines next wave of obesity therapy
The European Congress on Obesity (ECO) 2026 has historically focused primarily on weight reduction. However, this year, a shift in…
-
Fractyl Health’s GLP-1 gene therapy trial given green light
Fractyl Health’s trial to evaluate a glucagon-like peptide-1 (GLP-1) gene therapy has been approved by European authorities. The open-label, first-in-human,…
-
Boehringer’s weight loss jab as good as Wegovy but not Zepbound
Boehringer Ingelheim’s (BI’s) weight loss jab has shown similar efficacy to Wegovy (semaglutide) but a strength inferior to Zebound (tirzepatide).…
-
ACC 2026: Meta-analysis supports CagriSema as superior first-line therapy in obesity
On 28 March, at the American College of Cardiology (ACC) 75th Annual Scientific Session & Expo in New Orleans, Louisiana,…
-
Wave’s stock crashes 50% on Phase I obesity data
Wave Life Sciences’ stock has crashed by nearly 50% after its Phase I obesity trial showed low levels of weight…
